Does transverse colon cancer spread to the extramesocolic lymph node stations?

References

• Artling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356(9224):93–96.
   PubMed Web of Science ®Google Scholar
• Hohenberger W, Weber K, Matzel K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal Dis. 2009;11(4):354–364.
   PubMed Web of Science ®Google Scholar
• Heald RJ, Moran BJ. Embryology and anatomy of the rectum. Semin Surg Oncol. 1998;15(2):66–71.
   PubMedGoogle Scholar
• Jamieson JK, Dobson JF. VII. Lymphatics of the colon: with special reference to the operative treatment of cancer of the colon. Ann Surg. 1909;50(6):1077–1090.
   PubMedGoogle Scholar
• West NP, Hohenberger W, Weber K, et al. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol. 2010;28(2):272–278.
   PubMed Web of Science ®Google Scholar
• West NP, Kobayashi H, Takahashi K, et al. Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol. 2012;30(15):1763–1769.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, West NP, Takahashi K, et al. Quality of surgery for stage III colon cancer: comparison between England, Germany, and Japan. Ann Surg Oncol. 2014;21(Suppl S3):398–S404.
   Web of Science ®Google Scholar
• Bertelsen CA, Neuenschwander AU, Jansen JE, Danish Colorectal Cancer Group, et al. Disease-free survival after complete mesocolic excision with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol. 2015;16(2):161–168.
   PubMed Web of Science ®Google Scholar
• Toyota S, Ohta H, Anazawa S, et al. Rationale for extent of lymph node dissection for right colon cancer. Dis Colon Rectum. 1995;38(7):705–711.
   PubMed Web of Science ®Google Scholar
• Sjövall A, Granath F, Cedermark B, et al. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol. 2007;14(2):432–440.
   PubMed Web of Science ®Google Scholar
• Saha S, Johnston G, Korant A, et al. Aberrant drainage of sentinel lymph nodes in colon cancer and its impact on staging and extent of operation. Am J Surg. 2013;205(3):302–305.
   PubMed Web of Science ®Google Scholar
• Stelzner S, Hohenberger W, Weber K, et al. Anatomy of the transverse colon revisited with respect to complete mesocolic excision and possible pathways of aberrant lymphatic tumor spread. Int J Colorectal Dis. 2016;31(2):377–384.
   PubMed Web of Science ®Google Scholar
• Perrakis A, Weber K, Merkel S, et al. Lymph node metastasis of carcinomas of transverse colon including flexures. Consideration of the extramesocolic lymph node stations. Int J Colorectal Dis. 2014;29(10):1223–1229.
   PubMed Web of Science ®Google Scholar
• Yüksel BC, Çetinkaya E. The transverse colon reconsider with respect to complete mesocolic excision and the greater omentum. Int J Colorectal Dis. 2016;31(8):1497.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Gospodarowicz M, Wittekind C. UICC TNM classification of malignant tumors, 7th edn. New York: John Wiley & Sons; 2009.
   Google Scholar
• American Cancer Society. Cancer facts and figures. 2009. Available from: http://www.cancer.org/docroot/STT/STT0.asp
   Google Scholar
• Chen SL, Bilchik A. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244(4):602–610.
   PubMed Web of Science ®Google Scholar
• Johnson PM, Porter GA, Ricciardi R, et al. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24(22):3570–3575.
   PubMed Web of Science ®Google Scholar
• André T, Boni C, Mounedji-Boudiaf L, Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–2351.
   PubMed Web of Science ®Google Scholar
• Willaert W, Mareel M, Van De Putte D, et al. Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon. Cancer Treat Rev. 2014;40(3):405–413.
   PubMed Web of Science ®Google Scholar
• Weber K, Merkel S, Perrakis A, et al. Is there a disadvantage to radical lymph node dissection in colon cancer? Int J Colorectal Dis. 2013;28(2):217–226.
   PubMed Web of Science ®Google Scholar
• Bertelsen CA, Bols B, Ingeholm P, et al. Lymph node metastases in the gastrocolic ligament in patients with colon cancer. Dis Colon Rectum. 2014;57(7):839–845.
   PubMed Web of Science ®Google Scholar